Zacks.com featured highlights include Halozyme Therapeutics, Phibro, Leidos and PDD Holdings
Chicago, IL – September 5, 2025 – Stocks in this week’s article are Halozyme Therapeutics HALO, Phibro Animal Health PAHC, Leidos LDOS and PDD Holdings Inc. PDD.
In the equity market, investments need to be prudently hedged to overcome uncertainties and limit losses related to external shocks. A question that often arises is whether one should resort to a value strategy that seeks discounted stocks or opt for growth investing in times of extreme market instability.
The investing track of the Oracle of Omaha over the past few decades and his gradual shift from being a pure-play value investor to a GARP (growth at a reasonable price) investor might give us all the answers.
Per the GARP theory, the strategic…
